BIOMAT Database Logo BIOMAT Database Logo

Very low maternal serum unconjugated estriol and prenatal diagnosis of steroid sulfatase deficiency. 1995

M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Simon Winter Institute of Human Genetics, Bnai Zion Medical Center, Haifa, Israel.

Twenty-four women out of 7,875 pregnant women who enrolled in a prenatal screening program showed extremely low levels of unconjugated estriol (< 0.15 MOM). In 19 cases, intrauterine fetal death was reported. In 1 case anencephalus was detected. In the remaining 4 cases apparently normal healthy babies (1 female and 3 males) were born following uneventful pregnancies. Physical examination of the 3 boys at 4-6 weeks revealed mild ichthyosis compatible with the X-linked type. Two of them had a positive family history of X-linked ichthyosis. The examination of the girl did not reveal any significant findings. In both cases in which amniocentesis was performed, low levels of steroid sulfatase and arylsulfatase C were found. The prevalence of X-linked ichthyosis in this study is higher than previously reported, i.e. 1:1,300 males. Our results suggest that the prenatal screening program for neural tube defects and for Down's syndrome is useful for the prenatal detection of X-linked ichthyosis as well. These results are in accordance with two recent reports. The implications regarding genetic counseling are discussed.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D005313 Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D005817 Genetic Counseling An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered. Counseling, Genetic,Genetic Counseling, Prenatal,Prenatal Genetic Counseling
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic

Related Publications

M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis.
April 1995, American journal of clinical pathology,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Unconjugated estriol as an indication for prenatal diagnosis of steroid sulfatase deficiency by in situ hybridization.
October 1998, Obstetrics and gynecology,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Association of undetectable unconjugated estriol on multiple marker screening with steroid sulfatase deficiency.
January 2004, Fetal diagnosis and therapy,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Prenatal diagnosis of placental steroid sulfatase deficiency.
November 1976, American journal of obstetrics and gynecology,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Estimation of gestational age and maternal serum steroid concentrations. Unconjugated estriol.
December 1980, Journal of steroid biochemistry,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
[Placental steroid sulfatase deficiency. Reduced estriol production].
October 1985, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency.
March 1997, American journal of obstetrics and gynecology,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Steroid sulfatase deficiency and contiguous gene deletion syndrome amongst pregnant patients with low serum unconjugated estriols.
October 2009, Prenatal diagnosis,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening.
October 1995, American journal of obstetrics and gynecology,
M David, and N Israel, and R Merksamer, and N Bar-Nizan, and Z Borochowitz, and H Bar-el, and I Yehudai, and H Dar
Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
February 1996, The Journal of reproductive medicine,
Copied contents to your clipboard!